FP9 recommendations BioMed Alliance

With preparations under way for the EU’s next Framework Programme for Research and Innovation (FP9), the BioMed Alliance has called for more robust EU support for health research. In a recent position paper, the alliance makes the case for increased funding for basic, clinical and translational research and for the development of a long-term vision and strategy involving the creation of a European Council for Health Research.

For EHA, which has actively contributed to the drafting of the recommendations and participated in meetings with the European Commission and European Parliament, the BioMed Alliance offers an excellent framework for its advocacy efforts aimed at more and better funding opportunities for hematology research.

Read the BioMed Alliance position paper here.

Last Updated on Tuesday 10 April 2018.